Yayınlar & Eserler

Yayın Ağı
Makaleler 34
Tümü (34)
SCI-E, SSCI, AHCI (24)
SCI-E, SSCI, AHCI, ESCI (31)
ESCI (7)
Scopus (33)
TRDizin (6)

1. Diagnostic utility of serum human epididymis protein 4, endocan, sialyl-tn, and neopterin in endometrial cancer

TOYRAN A., Minareci Y., Sozen H., Tosun O. A., KÜÇÜKGERGİN C., Aydin F., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.36, sa.2, 2026 (SCI-Expanded, Scopus) identifier

2. The evaluation of miRNA-204 and miRNA-652-3p as serum biomarkers for endometrial cancer diagnosis and prognosis

Minareci Y., Sozen H., TOYRAN A., Tosun O. A., KÜÇÜKGERGİN C., GENÇ İ., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.36, sa.2, 2026 (SCI-Expanded, Scopus) identifier

3. Comparison of disease-free survival, overall survival, and complications between patients with advanced ovarian cancer receiving neoadjuvant systemic chemotherapy with or without HIPEC

Durak D. K., TOYRAN A., Minareci Y., Sozen H., TOPUZ S., Salihoglu M. Y.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.36, sa.2, 2026 (SCI-Expanded, Scopus) identifier

4. Serum lncRNA HOTAIRM1, but not miR-182-5p, as a Potential Non-Invasive Biomarker for Endometrial Cancer

Ulusoy H. E., Minareci Y., Kucukgergin C., Aydin A. F., Sozen H., Efe M. A., et al.
Clinical and Experimental Obstetrics and Gynecology , cilt.53, sa.2, 2026 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

5. Serum expression levels of HOTAIR and miR-646 in endometrial cancer.

Harismunandar R., Karpuzoğlu H., Minareci Y., Sözen H., Topuz S., Küçükgergin C., et al.
Oncology letters , cilt.31, sa.2, ss.90, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

6. Evaluation of total retroperitoneal en-bloc resection of multivisceral-peritoneal packet (TROMP) in advanced ovarian cancer: A single-center cohort study.

Sozen H., Minareci Y., Toyran A., Tutar E., AHMED M. A., Topuz S., et al.
Gynecologic oncology , cilt.201, ss.102-108, 2025 (SCI-Expanded, Scopus) identifier identifier

7. Predictors and treatment of ısolated recurrence in vulvar cancer confined to the vulva or perineum

Güngördük K., Demirkiran F., Khatib G., Öz M., GÜLSEREN V., Minareci Y., et al.
Journal of cancer research and therapeutics , cilt.21, sa.5, ss.1059-1063, 2025 (SCI-Expanded) identifier identifier identifier

8. Reflections on the HORSE Trial: Hyperthermic Intraperitoneal Chemotherapy, BRCA Status, and Clinical Implications

Sözen H., Minareci Y., Toyran A., Albayrak M., Topuz S., Salihoglu Y.
Journal of Clinical Oncology , cilt.43, sa.16, ss.1932, 2025 (SCI-Expanded, Scopus) identifier identifier

9. Carbon dye versus indocyanine green for sentinel lymph node mapping in endometrial cancer: a prospective dual-center study

Minareci Y., Sozen H., Bayram A., Hacioglu B. A., Yuvanc H. O., Murdan R., et al.
International Journal of Gynecological Cancer , cilt.35, sa.6, 2025 (SCI-Expanded, Scopus) identifier identifier

10. Predicting recurrence in adult granulosa cell tumors: the role of Ki67, p53, and TERT mutations

Bayram A., Bagbudar S., Yılmaz İ., Sozen H., Minareci Y., Altay A. Y., et al.
Archives of Gynecology and Obstetrics , cilt.311, sa.2, ss.415-421, 2025 (SCI-Expanded, Scopus) identifier identifier

11. CHIPOR: gaps in recurrent ovarian cancer management

Toyran A., Sozen H., Minareci Y., Topuz S., Salihoglu Y.
The Lancet Oncology , cilt.26, sa.2, 2025 (SCI-Expanded) identifier

12. Prognostic value of chemotherapy response score in advanced ovarian cancer: a single-center retrospective analysis

Sözen H., Minareci Y., Toyran A., YALÇIN İ., Önder S., Bayram A., et al.
Sao Paulo medical journal = Revista paulista de medicina , cilt.143, sa.6, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

13. Prognostic Value of p16INK4A and Ki67 Co-expression in Patients with Vaginal Intraepithelial Neoplasia

Minareci Y., AK N., Bayram A., Tosun O. A., Murdan R., Onder S., et al.
INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY , cilt.22, sa.2, 2024 (ESCI) identifier identifier

14. The evaluation of miR-1181 and miR-4314 as serum microRNA biomarkers for epithelial ovarian cancer diagnosis and prognosis.

Minareci Y., Ak N., Sozen H., Tosun O. A., Kucukgergin C., Aydin F., et al.
Molecular biology reports , cilt.51, sa.1, ss.515, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

15. Sentinel lymph node biopsy with carbon dye in endometrial cancer: a single center, prospective cohort study

Minareci Y., Sozen H., Altinkara Hacioglu B., Yuvanc H. O., Topuz S., Salihoglu M. Y.
Surgical Endoscopy , cilt.38, sa.3, ss.1608-1616, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

16. RECONSTRUCTION OPTIONS FOR CHALLENGING PERINEAL DEFECTS ZORLAYICI PERINE DEFEKTLERINDE ONARIM SEÇENEKLERI

Aksöyler D., Nergizogullari M. C., Yalçin Y., Kozanoglu E., Akalin B. E., Ercan L. D., et al.
Istanbul Tip Fakultesi Dergisi , cilt.87, sa.4, ss.275-282, 2024 (ESCI, Scopus, TRDizin) identifier

17. Comparison of Veress needle and direct trocar technique during laparoscopic initial entry via Palmer's point

MİNARECİ Y., Yuvanc H. O.
CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY , cilt.89, sa.6, ss.451-458, 2024 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier

18. MICRORNA 1181 AND 4314 AS PROMISING BIOMARKERS FOR EPITHELIAL OVARIAN CANCER DIAGNOSIS AND PROGNOSIS

MİNARECİ Y., AK N., SÖZEN H., Tosun O. A., KÜÇÜKGERGİN C., AYDIN F., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 2023 (SCI-Expanded, Scopus) identifier

19. Central nervous system metastasis in gynecologic cancers: Seeking the prognostic factors

Minareci Y., AK N., Tosun O. A., Sozen H., SAİP P. M., Topuz S., et al.
Journal of Cancer Research and Therapeutics , cilt.19, 2023 (SCI-Expanded, Scopus) identifier identifier

20. Prolongation of Neoadjuvant Chemotherapy before Surgery: Seeking the Optimal Number of Cycles in Serous Ovarian Cancer

Minareci Y., Sozen H., Ak N., Tosun O. A., Saip P., Salihoglu M. Y., et al.
CHEMOTHERAPY , cilt.67, ss.1-11, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

21. Predictors of high-grade residual disease after repeat conization in patients with positive surgical margins

Minareci Y., AK N., Tosun O. A., Sozen H., Disci R., Topuz S., et al.
Ginekologia polska , cilt.93, sa.12, ss.962-967, 2022 (Scopus) identifier identifier

22. Preoperative Minimal-Residue Diet Versus Fasting Alone in Minimally Invasive Gynecologic Surgery

Minareci Y., Portakal S.
JOURNAL OF GYNECOLOGIC SURGERY , cilt.37, ss.485-490, 2021 (ESCI) identifier identifier

23. Skeletal system as a rare metastatic site in patients with ovarian carcinoma

Ak N., Minareci Y., Saip P.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.31, sa.8, ss.1125-1131, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

24. Malignancy Algorithms in The Preoperative Assessment of Suspicious Adnexal Masses During Pregnancy

MINARECI Y., TOSUN Ö., Ak N., SÖZEN H., TOPUZ S., SALIHOGLU M. Y.
Kocaeli Tıp Dergisi , cilt.10, sa.3, ss.217-224, 2021 (Hakemli Dergi) Creative Commons License identifier

25. rFSH Versus Transvaginal Hydrolaparoscopic Ovarian Drilling in Patients with Polycystic Ovary Syndrome Resistant to Ovulation Induction

Minareci Y., Portakal S.
JOURNAL OF REPRODUCTIVE MEDICINE , cilt.66, ss.40-46, 2021 (SCI-Expanded) identifier identifier

26. Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma

Naziye A. K., Paksoy N., Ferhatoglu F., Aydin E., Dogan I., Bektas E., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.36, ss.438-445, 2021 (ESCI) identifier identifier identifier

27. A retrospective clinical analysis of hyperthermic intraperitoneal chemotherapy in gynecological cancers: Technical details, tolerability, and efficacy Jinekolojik kanserlerde hipertermik intraperitoneal kemoterapinin retrospektif olarak değerlendirilmesi: Teknik detay, tolerabilitesi ve etkilinliği

Minareci Y., Tosun O. A., Sozen H., Topuz S., Salihoglu M. Y.
Medeniyet Medical Journal , cilt.35, sa.3, ss.202-211, 2020 (Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

28. Clinicopathologic and survival results in serous endometrium carcinoma and subgroup analysis for mixed serous and pure serous histology

Kaban A., Topuz S., Sozen H., Minareci Y., Salihoglu Y.
JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION , cilt.19, sa.1, ss.23-28, 2018 (ESCI) Sürdürülebilir Kalkınma identifier identifier identifier

29. Maternal and fetal adropin levels in gestational diabetes mellitus

Celik E., YILMAZ E., Celik O., Ulas M., TÜRKÇÜOĞLU I., KARAER A., et al.
JOURNAL OF PERINATAL MEDICINE , cilt.41, sa.4, ss.375-380, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

30. Maternal and fetal serum orexin-A levels in gestational diabetes mellitus

YILMAZ E., CELIK O., CELIK N., CELIK E., TURKCUOGLU I., SIMSEK Y., et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , cilt.39, sa.1, ss.139-145, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

31. A comparative study on oxidative and antioxidative markers of serum and follicular fluid in GnRH agonist and antagonist cycles

Celik E., Celik O., Kumbak B., YILMAZ E., TÜRKÇÜOĞLU I., Simsek Y., et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS , cilt.29, sa.11, ss.1175-1183, 2012 (SCI-Expanded) identifier identifier identifier

32. Meigs' syndrome with elevated serum CA125: Case report and review of the literature Serum CA125 Yüksekli̇ǧi̇ i̇le Bi̇rli̇kte Olan Mei̇gs Sendromu: Olgu Sunumu Ve Li̇teratürün Gözden Geçi̇ri̇lmesi̇

YILMAZ E., Tanrikut E., KARAER A., ŞImşek Y., Çelik Ö., Minareci Y.
Turk Jinekoloji ve Obstetrik Dernegi Dergisi , cilt.9, ss.22-25, 2012 (ESCI) identifier identifier

33. Changes in serum obestatin, preptin and ghrelins in patients with Gestational Diabetes Mellitus

Baykus Y., Gurates B., Aydin S., Celik H., Kavak B., Aksoy A., et al.
CLINICAL BIOCHEMISTRY , cilt.45, sa.3, ss.198-202, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

34. Surgical termination of pregnancy: evaluation of 14,903 cases.

AKTUN H., CAKMAK P., MOROY P., Minareci Y., YALCIN H., MOLLAMAHMUTOGLU L., et al.
Taiwanese journal of obstetrics & gynecology , cilt.45, ss.221-4, 2006 (SCI-Expanded, Scopus) identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. İleri Evre Over Kanserinde Kemoterapi Yanıt Skorunun Prognostik Değeri Tek Merkez Analizi.

SÖZEN H., MİNARECİ Y., TOYRAN A., YALÇIN İ., ÖNDER S., BAYRAM A., et al.
TÜRK JİNEKOLOJİK ONKOLOJİ DERNEĞİ & SERVİKAL PATOLOJİLER VE KOLPOSKOPİ DERNEĞİ ULUSAL KONGRESİ, Ankara, Türkiye, 5 - 07 Aralık 2024, (Özet Bildiri)

2. Investigation of mirna-193b Expression and Stathmin 1 Level in Serum of Patients with Epithelial Ovary Cancer

Örskaya H. H., Minareci Y., Küçükgergin C., Aydin A. F., Salihoğlu M. Y., Sözen H., et al.
XXXIII. WASPaLM World Congress and XXIV. National Clinicial Biochemistry Congress, Antalya, Türkiye, 16 - 20 Ekim 2024, ss.94, (Özet Bildiri)

3. MICRORNA 1181 AND 4314 AS PROMISING BIOMARKERS FOR EPITHELIAL OVARIAN CANCER DIAGNOSIS AND PROGNOSIS

Minareci Y., Ak N., Sözen H., Tosun Ö., Küçükgergin C., Aydın A. F., et al.
ESGO 2023 European Congress on Gynaecological Oncology, İstanbul, Türkiye, 28 Eylül - 01 Ekim 2023, cilt.33, ss.242, (Özet Bildiri)

4. ENDOMETRİUM KANSERİNDE SERUM HOXB-AS1 GEN EKSPRESYONUNUN ETKİSİ

Kılınç S., Bingül İ., Küçükgergin C., Minareci Y., Sözen H., Topuz S., et al.
Uluslararası Katılımlı XXIII. Ulusal Klinik Biyokimya Kongresi, Antalya, Türkiye, 27 - 30 Nisan 2023, ss.154, (Özet Bildiri) Sürdürülebilir Kalkınma
Metrikler

Yayın

38

Yayın (WoS)

31

Yayın (Scopus)

33

Atıf (WoS)

131

H-İndeks (WoS)

5

Atıf (Scopus)

162

H-İndeks (Scopus)

5

Atıf (Diğer Toplam)

30

Proje

6

Açık Erişim

3
BM Sürdürülebilir Kalkınma Amaçları